Addressing NDMAs in Pharmaceuticals

Addressing NDMAs in Pharmaceuticals

Dr. Reddy’s API participated in an exclusive presentation entitled “Addressing NDMAs in Pharmaceuticals” at CPHI on NDMAs in Pharmaceuticals by our Executive Vice President and Head of API Regulatory affairs, E Sreedhar, and our VP and Head of Chemistry (API R&D), Rakeshwar Bandichhor.

Contact Us

Phone
Select Country *
Select Product
OR
Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patents Act (Bolar Exemption) and not for commercial sale.